AbbVie After Purchase Apogee? Is It a Buy Now for Investors
AbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
Investing in cryptocurrency? Discover what not to do to avoid costly mistakes and make informed decisions for a successful investment journey.
26,390 articlesAbbVie is expanding its immunology portfolio with Apogee Therapeutics. This guide explains what the deal adds, how it...
July 1 brought a sharp move for CoreWeave as a Bloomberg note about Meta expanding into cloud services rattled AI inf...
Sandisk stock bounced back today as traders weighed memory price signals and broader tech trends. This guide breaks d...
In 2026, investors face a choice between steady large-cap growth and the higher upside (and volatility) of small-cap ...
Alphabet’s cloud momentum is reshaping the risk-and-reward profile for investors. This article explains why the googl...
Japan stocks have been catching the market's eye as ishares msci japan surged. This guide breaks down why now and how...
A hedge fund's sizable exit from Protagonist Therapeutics highlights how insiders and funds shape biotech stock moves...
Investors are watching a potential shift at HubSpot as AI features expand across its platform. This guide breaks down...
When a superstar launches a first-of-its-kind anime, money talks as loudly as fans. This article breaks down the fina...
A recent move shows Bamco expanding its exposure to FactSet, highlighting the power of subscription-based data platfo...
More than 100 million U.S. adults cannot pay their credit-card balances in full, a sign of growing financial strain a...
An insurer’s blockbuster profit alongside an insider stock sale creates a compelling investing puzzle. This article b...